Correlation Between Propanc Biopharma and Regen BioPharma
Can any of the company-specific risk be diversified away by investing in both Propanc Biopharma and Regen BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Propanc Biopharma and Regen BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Propanc Biopharma and Regen BioPharma, you can compare the effects of market volatilities on Propanc Biopharma and Regen BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Propanc Biopharma with a short position of Regen BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Propanc Biopharma and Regen BioPharma.
Diversification Opportunities for Propanc Biopharma and Regen BioPharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Propanc and Regen is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Propanc Biopharma and Regen BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regen BioPharma and Propanc Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Propanc Biopharma are associated (or correlated) with Regen BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regen BioPharma has no effect on the direction of Propanc Biopharma i.e., Propanc Biopharma and Regen BioPharma go up and down completely randomly.
Pair Corralation between Propanc Biopharma and Regen BioPharma
If you would invest 1,445 in Regen BioPharma on August 31, 2024 and sell it today you would lose (1,435) from holding Regen BioPharma or give up 99.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Propanc Biopharma vs. Regen BioPharma
Performance |
| Timeline |
| Propanc Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Regen BioPharma |
Propanc Biopharma and Regen BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Propanc Biopharma and Regen BioPharma
The main advantage of trading using opposite Propanc Biopharma and Regen BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Propanc Biopharma position performs unexpectedly, Regen BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regen BioPharma will offset losses from the drop in Regen BioPharma's long position.| Propanc Biopharma vs. Nouveau Life Pharmaceuticals | Propanc Biopharma vs. Kali Inc | Propanc Biopharma vs. Endonovo Therapeutics | Propanc Biopharma vs. BioRestorative Therapies |
| Regen BioPharma vs. Therapeutic Solutions International | Regen BioPharma vs. Alpha Cognition | Regen BioPharma vs. Regen BioPharma | Regen BioPharma vs. Vg Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges |